Apyx Medical Inc (APYX) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Apyx Medical Inc (APYX) has a cash flow conversion efficiency ratio of -0.044x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-572.00K) by net assets ($13.09 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See APYX equity to assets ratio to measure how much of total assets are equity-financed.
Apyx Medical Inc - Cash Flow Conversion Efficiency Trend (1995–2025)
This chart illustrates how Apyx Medical Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Apyx Medical Inc cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
Apyx Medical Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Apyx Medical Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Becamex Infrastructure Development JSC
VN:IJC
|
-0.044x |
|
Black Spade Acquisition III Co
NYSE:BIII
|
-0.002x |
|
Lee Enterprises Incorporated
NASDAQ:LEE
|
1.974x |
|
Jean Co Ltd
TW:2442
|
0.583x |
|
Readly International AB
ST:READ
|
0.372x |
|
Iris Acquisition Corp II
NYSE:IRAB
|
0.000x |
|
Gemini Space Station, Inc. Class A Common Stock
NASDAQ:GEMI
|
-0.255x |
|
New England Realty Associates LP
NYSE MKT:NEN
|
-0.029x |
Annual Cash Flow Conversion Efficiency for Apyx Medical Inc (1995–2025)
The table below shows the annual cash flow conversion efficiency of Apyx Medical Inc from 1995 to 2025. For the full company profile with market capitalisation and key ratios, see market cap of Apyx Medical Inc.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $14.83 Million | $-8.00 Million | -0.539x | +57.15% |
| 2024-12-31 | $14.34 Million | $-18.05 Million | -1.259x | -545.71% |
| 2023-12-31 | $26.92 Million | $-5.25 Million | -0.195x | +63.67% |
| 2022-12-31 | $37.79 Million | $-20.28 Million | -0.537x | -177.36% |
| 2021-12-31 | $54.01 Million | $-10.45 Million | -0.193x | +23.10% |
| 2020-12-31 | $63.86 Million | $-16.07 Million | -0.252x | +2.96% |
| 2019-12-31 | $71.26 Million | $-18.48 Million | -0.259x | -8.30% |
| 2018-12-31 | $87.77 Million | $-21.01 Million | -0.239x | -42.39% |
| 2017-12-31 | $22.03 Million | $-3.70 Million | -0.168x | -55.40% |
| 2016-12-31 | $26.22 Million | $-2.84 Million | -0.108x | +56.24% |
| 2015-12-31 | $23.40 Million | $-5.79 Million | -0.247x | -178.29% |
| 2014-12-31 | $4.69 Million | $-417.00K | -0.089x | +25.28% |
| 2013-12-31 | $21.33 Million | $-2.54 Million | -0.119x | -1749.74% |
| 2012-12-31 | $22.89 Million | $165.00K | 0.007x | -91.60% |
| 2011-12-31 | $22.12 Million | $1.90 Million | 0.086x | +429.82% |
| 2010-12-31 | $21.77 Million | $-566.00K | -0.026x | -459.43% |
| 2009-12-31 | $21.15 Million | $-98.33K | -0.005x | -111.76% |
| 2008-12-31 | $18.79 Million | $742.83K | 0.040x | -67.48% |
| 2007-12-31 | $16.79 Million | $2.04 Million | 0.122x | -42.27% |
| 2006-12-31 | $14.18 Million | $2.99 Million | 0.211x | +1204.09% |
| 2005-12-31 | $9.94 Million | $-189.62K | -0.019x | -108.64% |
| 2004-12-31 | $9.26 Million | $2.04 Million | 0.221x | +297.81% |
| 2003-12-31 | $7.45 Million | $413.52K | 0.056x | +387.04% |
| 2002-12-31 | $6.49 Million | $73.98K | 0.011x | -91.52% |
| 2001-12-31 | $7.00 Million | $940.78K | 0.134x | +30.68% |
| 2000-12-31 | $6.39 Million | $657.50K | 0.103x | +16.53% |
| 1999-12-31 | $6.01 Million | $530.72K | 0.088x | +5950.81% |
| 1998-12-31 | $9.29 Million | $-14.01K | -0.002x | +96.60% |
| 1997-12-31 | $2.22 Million | $-98.79K | -0.044x | -121.09% |
| 1996-12-31 | $2.02 Million | $425.30K | 0.211x | +594.39% |
| 1995-12-31 | $412.30K | $12.50K | 0.030x | -- |
About Apyx Medical Inc
Apyx Medical Corporation, an energy technology company, designs, develops, manufactures, and sells electrosurgical equipment and medical devices in the United States and internationally. The company operates through two segments: Surgical Aesthetics and Original Equipment Manufacturing (OEM). It offers helium plasma generator for the delivery of RF energy and helium plasma to cut, coagulate, and … Read more